Search Results
The need for guidelines on cfDNA analysis in patients with lung cancer
The application of liquid biopsy ctDNA analysis in NSCLC
Adding CNVs and Fusions to a Lung cfDNA Assay: Impact on Oncology Clinical Research
Detection of mutations from liquid biopsies - applications in cancer diagnostics
RESECTABLE NSCLC AND THE IMPORTANCE OF GUIDELINE-RECOMMENDED MOLECULAR TESTING
Tracy Stockley - Variant detection in cell-free DNA from NSCLC using NGS
"Circulating tumour DNA: An increasingly powerful diagnostic tool for oncology" - Nitzan Rosenfeld
Molecular Testing for EGFR Mutations: What Pathologists Need to Know
From Qualitative to Quantitative: Experiences with a cfDNA Assay in Metastatic Breast Cancer
2021 Liquid Biopsy EQA for lung cancer (EGFR) webinar - 21st April 2022
Monitoring circulating tumor DNA in Non-Small Cell Lung Cancer patients by targeted NGS
Evaluation of a Pan-Cancer Cell-Free Assay to Meet Unmet Research Needs
